Form D · Biotechnology
TearSolutions, Inc.
Charlottesville, VA · CIK 0001611687
Offering snapshot reported Nov 10, 2025 · SEC filing
- Reported sold
- $517K Offering amount: $517K
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 29, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2025 | Initial | $517,000 | No comparison | 12 | SEC filing |
| Oct 9, 2024 | Initial | $12,709,989 | No comparison | 80 | SEC filing |
| Aug 12, 2024 | Initial | $390,000 | No comparison | 10 | SEC filing |
| Jan 24, 2022 | Initial | $5,624,634 | No comparison | 44 | SEC filing |
| Feb 26, 2020 | Initial | $1,499,595 | No comparison | 36 | SEC filing |
| Apr 18, 2019 | Amendment | $1,332,364 | $446,943vs Mar 19, 2019 | 16 | SEC filing |
| Apr 18, 2019 | Amendment | $5,118,562 | $1,075,737vs Mar 19, 2019 | 22 | SEC filing |
| Mar 19, 2019 | Initial | $885,421 | No comparison | 13 | SEC filing |
| Mar 19, 2019 | Initial | $4,042,825 | No comparison | 19 | SEC filing |
| Dec 19, 2017 | Initial | $8,056,619 | No comparison | 24 | SEC filing |
| May 5, 2017 | Amendment | $3,410,334 | $2,329,988vs Feb 24, 2017 | 22 | SEC filing |
| Feb 24, 2017 | Initial | $1,080,346 | No comparison | 12 | SEC filing |
| Nov 12, 2014 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jun 25, 2014 | Initial | $390,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563547
Source: Form D, filed Nov 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Louis M Alpern | Director |
| Anil W Asrani | Director, Executive |
| Jens Biertumpel | Director |
| Leonard Borrmann | Director |
| Michelle Carpenter | Executive |
| Alexey Chernushkin | Director |
| Robert J Dempsey | Director, Executive |
| Konstantine Drakonakis | Director |
| Tom Gadek | Director, Executive |
| Thomas Gadek | Director, Executive |
| Laurie Gordon | Executive |
| Bruce Kuper | Director |
| Bruce P. Kupper | Director |
| Gordon W Laurie | Executive |
| Mark B Logan | Director |
| John Moore | Executive |
| Marc Odrich | Executive |
| James M Ramey | Director |
| Colin M Rolph | Executive |
| Amir W Shojaei | Director |
| Mac Thompson | Executive |
| W. Mc Ilwaine Thompson, Jr. | Executive |
| William Mc Ilwaine Thompson, Jr. | Executive |
| Alexey Vinogradov | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
315 Old Ivy Way Suite 301
Charlottesville, VA, 22903
Charlottesville, VA, 22903